Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021Masayuki Teramoto, Muayyad Ahmad, Rizwan Suliankatchi Abdulkader et al.|The Lancet|2025Cited by 801
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023Masayuki Teramoto, Hassan Abolhassani, Kanyin Liane Ong et al.|The Lancet|2025Cited by 386
Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023Mohsen Naghavi, Masayuki Teramoto, Rana Abu Farha et al.|The Lancet|2025Cited by 259
Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023Masayuki Teramoto, Bilyaminu Abubakar, Peng Zheng et al.|The Lancet|2025Cited by 99
Role of AXL in invasion and drug resistance of colon and breast cancer cells and its association with p53 alterationsWael M. Abdel‐Rahman, Maha Saber-Ayad|World Journal of Gastroenterology|2017Cited by 30